Pimavanserin May Hold Promise for Alzheimer ' s Psychosis Pimavanserin May Hold Promise for Alzheimer ' s Psychosis

Pimavanserin reduced psychosis at 6 weeks in patients with Alzheimer ' s disease compared with placebo. But at least one expert says the findings may simply be due to chance.Medscape Medical News
Source: Medscape Psychiatry Headlines - Category: Psychiatry Tags: Neurology & Neurosurgery News Source Type: news